- Disinfector
- Equipment
- Sterilization Equipment
- Services
- Consumables
Hospital Acquired Infection Control Market size was valued at USD 10.17 billion in 2022 and is poised to grow at a CAGR of 11.2% from 2023-2029. Hospital acquired infections (HAIs) is a noteworthy security worry for both human services suppliers and the patients. Thinking about bleakness, mortality, expanded length of stay and the cost, endeavors ought to be made to make the healing facilities as protected as conceivable by forestalling such diseases. The hospital-acquired infection control market is very aggressive and comprises of driving pharmaceutical organizations who represent most the pieces of the overall industry. Organizations with restricted experience are creating imaginative answers for control doctor's facility gained diseases. Interests in the assembling to grow generation offices and impressive endeavors to create propelled drugs that can fix hospital-acquired infection control are the key procedures utilized by the market players. To extend the client base, some key organizations are additionally concentrating on launching products with impartial costs that can be productive for the organization and moderate for the patients.
Hospital Acquired Infection Control Market Key Developments:
In January 2017, Advanced Sterilization Products propelled STERRAD 100NX System with ALLClear in the U.S and is intending to extend its impression into districts, for example, Europe, Africa and Middle East. This market research report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.
Hospital Acquired Infection Control Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
11.2%
Largest Market
North America
Fastest Growing Market
North America
Hospital- Acquired Infection Control Market Dynamics
The ascent in the occurrences of various kinds of hospital-acquired infections, creative advances actualized in gadgets that control disease, mindfulness in regards to the utilization of customized pharmaceuticals, and cost-effective medications to treat hospital-acquired infections are a portion of the elements that are driving the development of this market. However, the absence of mindfulness with respect to hospital-acquired infections and expanded utilization of outpatient treatment are hampering the development of this hospital-acquired infections market.
North-America Got Significant Share
Hospital- Acquired Infection Control Market Regional Analysis
Geographically Hospital-acquired Infection Control Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America represented an overwhelming offer of the Hospital-acquired Infection Control market. Steady number of key coordinated efforts embraced by key market players to augment their product portfolio and disease control abilities are accepted to be in charge of the more prominent offer caught by this region. The Asia Pacific market is required to display the speediest CAGR all through the gauge time frame attributable to the developing nearness of outsourcing associations, developing social insurance use, and uncommon advancement of the medicinal services guidelines and foundation over this locale. Nearness of different deliberate and government associations concentrated on enhancing disease control measures is likewise one of the critical elements contributing toward the development of Asia Pacific area.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The hospital acquired infection control market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Hospital Acquired Infection Control Market Segmentation
By Type of Treatment
By End User
- Hospitals
- Clinical Laboratories
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa (MEA)
Frequently Asked Questions
The hospital-acquired infection control market size was valued at USD 10.17 billion in 2022
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The hospital-acquired infection control market key players are Steris Corporation (U.S.), Becton, Dickinson and Company (U.S.), Advanced Sterilization Products (U.S.), Getinge Group (Sweden), Cantel Medical (U.S.), Kimberly-Clark Corporation (U.S.)
| 1.Executive Summary |
| 2.Global Hospital Acquired Infection Control Market Introduction |
| 2.1.Global Hospital Acquired Infection Control Market - Taxonomy |
| 2.2.Global Hospital Acquired Infection Control Market - Definitions |
| 2.2.1. By Type of Treatment |
| 2.2.2. By End User |
| 2.2.3. By Region |
| 3.Global Hospital Acquired Infection Control Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Hospital Acquired Infection Control Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Hospital Acquired Infection Control Market By Type of Treatment, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Disinfector |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Equipment |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Sterilization Equipment |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Services |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Consumables |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6.Global Hospital Acquired Infection Control Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Clinical Laboratories |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Hospital Acquired Infection Control Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Hospital Acquired Infection Control Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Type of Treatment Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Disinfector |
| 8.1.2.Equipment |
| 8.1.3.Sterilization Equipment |
| 8.1.4.Services |
| 8.1.5.Consumables |
| 8.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Clinical Laboratories |
| 8.2.3.Others |
| 8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Hospital Acquired Infection Control Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Type of Treatment Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Disinfector |
| 9.1.2.Equipment |
| 9.1.3.Sterilization Equipment |
| 9.1.4.Services |
| 9.1.5.Consumables |
| 9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Clinical Laboratories |
| 9.2.3.Others |
| 9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Hospital Acquired Infection Control Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Type of Treatment Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Disinfector |
| 10.1.2.Equipment |
| 10.1.3.Sterilization Equipment |
| 10.1.4.Services |
| 10.1.5.Consumables |
| 10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Clinical Laboratories |
| 10.2.3.Others |
| 10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Hospital Acquired Infection Control Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Type of Treatment Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Disinfector |
| 11.1.2.Equipment |
| 11.1.3.Sterilization Equipment |
| 11.1.4.Services |
| 11.1.5.Consumables |
| 11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Clinical Laboratories |
| 11.2.3.Others |
| 11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Hospital Acquired Infection Control Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Type of Treatment Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Disinfector |
| 12.1.2.Equipment |
| 12.1.3.Sterilization Equipment |
| 12.1.4.Services |
| 12.1.5.Consumables |
| 12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Clinical Laboratories |
| 12.2.3.Others |
| 12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Steris Corporation (U.S.) |
| 13.2.2.Becton, Dickinson and Company (U.S.) |
| 13.2.3.Advanced Sterilization Products (U.S.) |
| 13.2.4.Getinge Group (Sweden) |
| 13.2.5.Cantel Medical (U.S.) |
| 13.2.6.Kimberly-Clark Corporation (U.S.) |
| 13.2.7.3M Company (U.S.) |
| 13.2.8.Belimed AG (Switzerland) |
| 13.2.9.Sterigenics International LLC. (U.S.) |
| 13.2.10.Synergy Health, plc (U.K.). |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Steris Corporation (U.S.)
- Becton, Dickinson and Company (U.S.)
- Advanced Sterilization Products (U.S.)
- Getinge Group (Sweden)
- Cantel Medical (U.S.)
- Kimberly-Clark Corporation (U.S.)
- BioMérieux SA (France)
- 3M Company (U.S.)
- Belimed AG (Switzerland)
- Sterigenics International LLC. (U.S.)
- Synergy Health, plc (U.K.).